ArticleCrohn's & colitis 3602019

Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab.

Phillip Minar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.